United States Hepatitis C Treatment Market Report 2017

Name: United States Hepatitis C Treatment Market Report 2017
Brand: QYResearch
SKU: U91C1156D28EN
Price: 3800 USD
Availability: InStock

November 2017 | 95 pages | ID: U91C1156D28EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Hepatitis C Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Hepatitis C Treatment in these regions, from 2012 to 2022 (forecast).

United States Hepatitis C Treatment market competition by top manufacturers/players, with Hepatitis C Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

AbbieVie Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche AG
Gilead Sciences Inc.
GlaxoSmith Kline Plc.
Janssen Pharmaceuticals Inc.
Merck & Co. Inc.
Schering AG
Vertex Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

HCV Protease Inhibitors
HCV Polymerase Inhibitors
HCV NS5A Inhibitors
Combination Therapy
Interferon and Antiviral
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospital
Clinic
Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Hepatitis C Treatment Market Report 2017

1 HEPATITIS C TREATMENT OVERVIEW

1.1 Product Overview and Scope of Hepatitis C Treatment
1.2 Classification of Hepatitis C Treatment by Product Category
  1.2.1 United States Hepatitis C Treatment Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Hepatitis C Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 HCV Protease Inhibitors
  1.2.4 HCV Polymerase Inhibitors
  1.2.5 HCV NS5A Inhibitors
  1.2.6 Combination Therapy
  1.2.7 Interferon and Antiviral
  1.2.8 Others
1.3 United States Hepatitis C Treatment Market by Application/End Users
  1.3.1 United States Hepatitis C Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Home Care
1.4 United States Hepatitis C Treatment Market by Region
  1.4.1 United States Hepatitis C Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Hepatitis C Treatment Status and Prospect (2012-2022)
  1.4.3 Southwest Hepatitis C Treatment Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Hepatitis C Treatment Status and Prospect (2012-2022)
  1.4.5 New England Hepatitis C Treatment Status and Prospect (2012-2022)
  1.4.6 The South Hepatitis C Treatment Status and Prospect (2012-2022)
  1.4.7 The Midwest Hepatitis C Treatment Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Hepatitis C Treatment (2012-2022)
  1.5.1 United States Hepatitis C Treatment Sales and Growth Rate (2012-2022)
  1.5.2 United States Hepatitis C Treatment Revenue and Growth Rate (2012-2022)

2 UNITED STATES HEPATITIS C TREATMENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Hepatitis C Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Hepatitis C Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Hepatitis C Treatment Average Price by Players/Suppliers (2012-2017)
2.4 United States Hepatitis C Treatment Market Competitive Situation and Trends
  2.4.1 United States Hepatitis C Treatment Market Concentration Rate
  2.4.2 United States Hepatitis C Treatment Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Hepatitis C Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HEPATITIS C TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Hepatitis C Treatment Sales and Market Share by Region (2012-2017)
3.2 United States Hepatitis C Treatment Revenue and Market Share by Region (2012-2017)
3.3 United States Hepatitis C Treatment Price by Region (2012-2017)

4 UNITED STATES HEPATITIS C TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Hepatitis C Treatment Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Hepatitis C Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Hepatitis C Treatment Price by Type (2012-2017)
4.4 United States Hepatitis C Treatment Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HEPATITIS C TREATMENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Hepatitis C Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Hepatitis C Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HEPATITIS C TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AbbieVie Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hepatitis C Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbieVie Inc. Hepatitis C Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb Company
  6.2.2 Hepatitis C Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Company Hepatitis C Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 F. Hoffmann-La Roche AG
  6.3.2 Hepatitis C Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 F. Hoffmann-La Roche AG Hepatitis C Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Gilead Sciences Inc.
  6.4.2 Hepatitis C Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Gilead Sciences Inc. Hepatitis C Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmith Kline Plc.
  6.5.2 Hepatitis C Treatment Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmith Kline Plc. Hepatitis C Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Janssen Pharmaceuticals Inc.
  6.6.2 Hepatitis C Treatment Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Janssen Pharmaceuticals Inc. Hepatitis C Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Merck & Co. Inc.
  6.7.2 Hepatitis C Treatment Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Merck & Co. Inc. Hepatitis C Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Schering AG
  6.8.2 Hepatitis C Treatment Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Schering AG Hepatitis C Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Vertex Pharmaceuticals
  6.9.2 Hepatitis C Treatment Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Vertex Pharmaceuticals Hepatitis C Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 HEPATITIS C TREATMENT MANUFACTURING COST ANALYSIS

7.1 Hepatitis C Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hepatitis C Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hepatitis C Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hepatitis C Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HEPATITIS C TREATMENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Hepatitis C Treatment Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Hepatitis C Treatment Sales Volume Forecast by Type (2017-2022)
11.3 United States Hepatitis C Treatment Sales Volume Forecast by Application (2017-2022)
11.4 United States Hepatitis C Treatment Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Hepatitis C Treatment
Figure United States Hepatitis C Treatment Market Size (K Pcs) by Type (2012-2022)
Figure United States Hepatitis C Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure HCV Protease Inhibitors Product Picture
Figure HCV Polymerase Inhibitors Product Picture
Figure HCV NS5A Inhibitors Product Picture
Figure Combination Therapy Product Picture
Figure Interferon and Antiviral Product Picture
Figure Others Product Picture
Figure United States Hepatitis C Treatment Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Hepatitis C Treatment by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Care Examples
Table Key Downstream Customer in Home Care
Figure United States Hepatitis C Treatment Market Size (Million USD) by Region (2012-2022)
Figure The West Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hepatitis C Treatment Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Hepatitis C Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hepatitis C Treatment Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Hepatitis C Treatment Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Hepatitis C Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hepatitis C Treatment Sales Share by Players/Suppliers
Figure 2017 United States Hepatitis C Treatment Sales Share by Players/Suppliers
Figure United States Hepatitis C Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Hepatitis C Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Hepatitis C Treatment Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hepatitis C Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Hepatitis C Treatment Revenue Share by Players/Suppliers
Table United States Market Hepatitis C Treatment Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Hepatitis C Treatment Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Hepatitis C Treatment Market Share of Top 3 Players/Suppliers
Figure United States Hepatitis C Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Hepatitis C Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Hepatitis C Treatment Product Category
Table United States Hepatitis C Treatment Sales (K Pcs) by Region (2012-2017)
Table United States Hepatitis C Treatment Sales Share by Region (2012-2017)
Figure United States Hepatitis C Treatment Sales Share by Region (2012-2017)
Figure United States Hepatitis C Treatment Sales Market Share by Region in 2016
Table United States Hepatitis C Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Hepatitis C Treatment Revenue Share by Region (2012-2017)
Figure United States Hepatitis C Treatment Revenue Market Share by Region (2012-2017)
Figure United States Hepatitis C Treatment Revenue Market Share by Region in 2016
Table United States Hepatitis C Treatment Price (USD/Pcs) by Region (2012-2017)
Table United States Hepatitis C Treatment Sales (K Pcs) by Type (2012-2017)
Table United States Hepatitis C Treatment Sales Share by Type (2012-2017)
Figure United States Hepatitis C Treatment Sales Share by Type (2012-2017)
Figure United States Hepatitis C Treatment Sales Market Share by Type in 2016
Table United States Hepatitis C Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Hepatitis C Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hepatitis C Treatment by Type (2012-2017)
Figure Revenue Market Share of Hepatitis C Treatment by Type in 2016
Table United States Hepatitis C Treatment Price (USD/Pcs) by Types (2012-2017)
Figure United States Hepatitis C Treatment Sales Growth Rate by Type (2012-2017)
Table United States Hepatitis C Treatment Sales (K Pcs) by Application (2012-2017)
Table United States Hepatitis C Treatment Sales Market Share by Application (2012-2017)
Figure United States Hepatitis C Treatment Sales Market Share by Application (2012-2017)
Figure United States Hepatitis C Treatment Sales Market Share by Application in 2016
Table United States Hepatitis C Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Hepatitis C Treatment Sales Growth Rate by Application (2012-2017)
Table AbbieVie Inc. Basic Information List
Table AbbieVie Inc. Hepatitis C Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbieVie Inc. Hepatitis C Treatment Sales Growth Rate (2012-2017)
Figure AbbieVie Inc. Hepatitis C Treatment Sales Market Share in United States (2012-2017)
Figure AbbieVie Inc. Hepatitis C Treatment Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Hepatitis C Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Hepatitis C Treatment Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Hepatitis C Treatment Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company Hepatitis C Treatment Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche AG Basic Information List
Table F. Hoffmann-La Roche AG Hepatitis C Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Hepatitis C Treatment Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Hepatitis C Treatment Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche AG Hepatitis C Treatment Revenue Market Share in United States (2012-2017)
Table Gilead Sciences Inc. Basic Information List
Table Gilead Sciences Inc. Hepatitis C Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Gilead Sciences Inc. Hepatitis C Treatment Sales Growth Rate (2012-2017)
Figure Gilead Sciences Inc. Hepatitis C Treatment Sales Market Share in United States (2012-2017)
Figure Gilead Sciences Inc. Hepatitis C Treatment Revenue Market Share in United States (2012-2017)
Table GlaxoSmith Kline Plc. Basic Information List
Table GlaxoSmith Kline Plc. Hepatitis C Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmith Kline Plc. Hepatitis C Treatment Sales Growth Rate (2012-2017)
Figure GlaxoSmith Kline Plc. Hepatitis C Treatment Sales Market Share in United States (2012-2017)
Figure GlaxoSmith Kline Plc. Hepatitis C Treatment Revenue Market Share in United States (2012-2017)
Table Janssen Pharmaceuticals Inc. Basic Information List
Table Janssen Pharmaceuticals Inc. Hepatitis C Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals Inc. Hepatitis C Treatment Sales Growth Rate (2012-2017)
Figure Janssen Pharmaceuticals Inc. Hepatitis C Treatment Sales Market Share in United States (2012-2017)
Figure Janssen Pharmaceuticals Inc. Hepatitis C Treatment Revenue Market Share in United States (2012-2017)
Table Merck & Co. Inc. Basic Information List
Table Merck & Co. Inc. Hepatitis C Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co. Inc. Hepatitis C Treatment Sales Growth Rate (2012-2017)
Figure Merck & Co. Inc. Hepatitis C Treatment Sales Market Share in United States (2012-2017)
Figure Merck & Co. Inc. Hepatitis C Treatment Revenue Market Share in United States (2012-2017)
Table Schering AG Basic Information List
Table Schering AG Hepatitis C Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Schering AG Hepatitis C Treatment Sales Growth Rate (2012-2017)
Figure Schering AG Hepatitis C Treatment Sales Market Share in United States (2012-2017)
Figure Schering AG Hepatitis C Treatment Revenue Market Share in United States (2012-2017)
Table Vertex Pharmaceuticals Basic Information List
Table Vertex Pharmaceuticals Hepatitis C Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Vertex Pharmaceuticals Hepatitis C Treatment Sales Growth Rate (2012-2017)
Figure Vertex Pharmaceuticals Hepatitis C Treatment Sales Market Share in United States (2012-2017)
Figure Vertex Pharmaceuticals Hepatitis C Treatment Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatitis C Treatment
Figure Manufacturing Process Analysis of Hepatitis C Treatment
Figure Hepatitis C Treatment Industrial Chain Analysis
Table Raw Materials Sources of Hepatitis C Treatment Major Players/Suppliers in 2016
Table Major Buyers of Hepatitis C Treatment
Table Distributors/Traders List
Figure United States Hepatitis C Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Hepatitis C Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Hepatitis C Treatment Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Hepatitis C Treatment Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Hepatitis C Treatment Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Hepatitis C Treatment Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Hepatitis C Treatment Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Hepatitis C Treatment Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Hepatitis C Treatment Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Hepatitis C Treatment Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Hepatitis C Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hepatitis C Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hepatitis C Treatment Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Hepatitis C Treatment Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports